Neurocrine Biosciences Market Sentiment

Neurocrine Biosciences Inc

NBIXNASDAQ

Trade with Public

$156.22

-0.35-0.22%

At close: Sep 11, 5:00 PM EST

$156.22

N/A

After Hours: Sep 11, 4:10 PM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Neurocrine Biosciences Market Sentiment

Market sentiment signals for Neurocrine Biosciences (NBIX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.5% short float

Options Flow▲ 0.71 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

26 analysts

Options Flow (P/C)

0.71

More calls — Bullish

21 calls · 15 puts

Avg Consensus PT

$199

+27.1%

Highest Price Target

$253

+62.0%

Citigroup

Lowest Price Target

$160

+2.4%

Wolfe Research

Short Interest

6.5%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 11, 2026	Morgan Stanley	Jeffrey Hung—	+17.1%	$182 → $183	Maintained	Equal-Weight
Sep 8, 2026	RBC Capital	Brian Abrahams—	+26.7%	$198 → $198	Maintained	Outperform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+62.0%	$249 → $253	Maintained	Buy
Aug 13, 2026	Morgan Stanley	Jeffrey Hung—	+16.5%	$196 → $182	Maintained	Equal-Weight
Aug 3, 2026	Canaccord Genuity	Sumant Kulkarni—	+34.4%	$200 → $210	Maintained	Buy
Aug 3, 2026	Truist Securities	Danielle Brill—	+36.3%	$200 → $213	Maintained	Buy
Aug 3, 2026	Wedbush	Laura Chico—	+24.2%	$185 → $194	Maintained	Outperform
Jul 31, 2026	Citigroup	Yigal Nochomovitz—	+59.4%	$246 → $249	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	+26.7%	$195 → $198	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Jeffrey Hung—	+25.5%	$193 → $196	Maintained	Equal-Weight
Jul 31, 2026	TD Cowen	Phil Nadeau—	+40.8%	$200 → $220	Maintained	Buy
Jul 31, 2026	Piper Sandler	David Amsellem—	+34.4%	$207 → $210	Maintained	Overweight
Jul 31, 2026	Cantor Fitzgerald	Josh Schimmer—	+37.6%	$210 → $215	Maintained	Overweight
Jul 31, 2026	Guggenheim	Yatin Suneja—	+42.1%	$200 → $222	Maintained	Buy
Jul 31, 2026	Stifel	Paul Matteis—	+37.6%	$188 → $215	Maintained	Buy
Jul 31, 2026	Needham	Ami Fadia—	+30.6%	$200 → $204	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+28.0%	$175 → $200	Maintained	Buy
Jul 17, 2026	Wells Fargo	Mohit Bansal—	+28.0%	$175 → $200	Maintained	Overweight
Jul 13, 2026	Truist Securities	Danielle Brill—	+28.0%	$155 → $200	Maintained	Buy
Jul 13, 2026	BMO Capital	Evan Seigerman—	+8.8%	$144 → $170	Maintained	Market Perform
Jul 7, 2026	RBC Capital	Brian Abrahams—	+24.8%	$183 → $195	Maintained	Outperform
Jun 2, 2026	Goldman Sachs	Corinne Johnson—	+36.3%	$213	Reinstates	Buy
May 29, 2026	RBC Capital	Brian Abrahams—	+17.1%	$180 → $183	Maintained	Outperform
May 22, 2026	Bernstein	Jeffrey Walch—	+41.5%	$221	Initiate	Outperform
May 8, 2026	JP Morgan	Anupam Rama—	+18.4%	$177 → $185	Maintained	Overweight